@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HS7N6HLJ-X
  skos:prefLabel "Dibenzoxazépines"@fr, "Dibenzoxazepines"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-MKX9XJT8-L .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-BN87VH98-Z
  skos:prefLabel "Antagonistes de la dopamine"@fr, "Dopamine Antagonists"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Z4BQ5GQ2-G
  skos:prefLabel "Amoxapine"@fr, "Amoxapine"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-MKX9XJT8-L .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FRV1PNZN-9
  skos:prefLabel "Antipsychotic Agents"@en, "Neuroleptiques"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-MKX9XJT8-L
  mesh:pharmacologicalAction jvr:-BN87VH98-Z, jvr:-FRV1PNZN-9 ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D008152> ;
  skos:broader jvr:-HS7N6HLJ-X ;
  a mesh:Descriptor, skos:Concept ;
  skos:altLabel "X59SG0MRYU"@fr, "X59SG0MRYU"@en, "376MYL4MAL"@fr, "376MYL4MAL"@en, "Cloxazepine"@en, "2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepine"@en, "20287-66-5 (maleate)"@fr, "20287-66-5 (maleate)"@en, "LER583670J"@fr, "LER583670J"@en, "1977-10-2 (Loxapine)"@fr, "1977-10-2 (Loxapine)"@en, "Dibenz(b,f)(1,4)oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-"@fr, "Dibenz(b,f)(1,4)oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-"@en, "54810-23-0 (mono-HCl)"@fr, "54810-23-0 (mono-HCl)"@en, "Oxilapine"@en ;
  skos:hiddenLabel "Loxapine Monohydrochloride"@en, "Loxitane"@en, "Loxipine Maleate"@en, "Loxapine Hydrochloride"@en, "Loxipine Succinate"@en, "CL-71,563"@en, "Loxapine Succinate"@en, "Loxapinsuccinate"@en ;
  skos:inScheme jvr: ;
  skos:narrower jvr:-Z4BQ5GQ2-G ;
  mesh:allowableQualifier jvr:-H7K65Q8S-Z, jvr:-BT300B3G-Q, jvr:-NB0XHT3S-N, jvr:-M63HSDM7-1, jvr:-WK5F724J-1, jvr:-T9HQD7ST-J, jvr:-TJHVZCRZ-0, jvr:-NFTHND7Q-8, jvr:-R3QWLHRG-V, jvr:-FWD2BGQ0-9, jvr:-NKM836P1-M, jvr:-HQRFT0C6-B, jvr:-G4R176S9-J, jvr:-THHNVC7V-3, jvr:-D0F21513-5, jvr:-S0CS1X5R-5, jvr:-CB30NGKB-3, jvr:-R0ZCQ8X6-J, jvr:-G30ZJ446-J, jvr:-L6C0XPHT-4, jvr:-SBNWSM1T-R, jvr:-W6SQV79N-S, jvr:-XV06LPML-W, jvr:-Q3979798-W, jvr:-NHL3D2X0-S ;
  dc:modified "2016-05-31"^^xsd:date ;
  skos:definition "An antipsychotic agent used in SCHIZOPHRENIA."@en ;
  skos:prefLabel "Loxapine"@fr, "Loxapine"@en ;
  dc:established "1991-01-01"^^xsd:date ;
  dc:created "1974-11-19"^^xsd:date .